Live Breaking News & Updates on Vanda pharmaceuticals stock

Stay updated with breaking news from Vanda pharmaceuticals stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]

Los-angeles , California , United-states , Vanda-pharmaceuticals-inc , Jacobs-levy-equity-management-inc , Nasdaq , Stonepine-capital-management , Capital-partners , Acadian-asset-management , Vanda-pharmaceuticals-company-profile , News-ratings-for-vanda-pharmaceuticals-daily

Vanda Pharmaceuticals (NASDAQ:VNDA) Receives New Coverage from Analysts at StockNews.com

Vanda Pharmaceuticals (NASDAQ:VNDA) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Timothy-williams , Kevin-patrick-moran , Capital-advisors-ltd , Vanda-pharmaceuticals-inc , Insider-transactions-at-vanda-pharmaceuticals , Securities-exchange-commission , Lazard-asset-management , Quadrant-capital-group , Vanda-pharmaceuticals , Vanda-pharmaceuticals-company-profile , Vanda-pharmaceuticals-stock , Hedge-funds-weigh-in-on-vanda-pharmaceuticals

Vanda Pharmaceuticals (NASDAQ:VNDA) Upgraded by StockNews.com to "Strong-Buy"

StockNews.com upgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Friday morning. Vanda Pharmaceuticals Stock Up 0.6 % Shares of Vanda Pharmaceuticals stock opened at $6.54 on Friday. The company’s fifty day simple moving average is $6.40 and its […]

News-ratings-for-vanda-pharmaceuticals-daily , Vanda-pharmaceuticals , Capital-advisors-ltd , Vanda-pharmaceuticals-stock , Institutional-investors-weigh-in-on-vanda-pharmaceuticals , Financial-services-group-inc , Vanda-pharmaceuticals-company-profile , Ghost-tree-capital , Pricet-rowe-associates-inc , Vanda-pharmaceuticals-inc , Get-rating